Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares purchased at a price of £12.13 per share, and Ordinary share ADRs purchased at a price of $47.89 per ADRin GlaxoSmithKline plc on 14 July 2008, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 10 July 2008.
|
Ordinary shares |
ADRs |
Mr A P Witty |
210.24 |
|
Mr J S Heslop |
42.33 |
|
Dr M M Slaoui |
61.80 |
|
Mrs C E Bruck Slaoui |
19.16 |
|
Mr C Viehbacher |
|
121.51 |
Mr S M Bicknell |
27.38 |
|
Mr J M Clarke |
130.72 |
|
Mr M Dunoyer |
79.18 |
|
Mr E J Gray |
79.46 |
|
Mr D Learmouth |
47.64 |
|
Mr W C Louv |
|
39.04 |
Mr D J Phelan |
|
119.17 |
Dr D Pulman |
|
68.94 |
Mr D S Redfern |
0.35 |
|
Ms C Thomas |
59.79 |
|
Mr J R Stéphenne |
221.56 |
|
Mr S M Werner |
|
39.72 |
The Company and the above named persons were advised of this information on 16 July 2008.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
17 July 2008